FilingReader Intelligence
Sinopharm Accord's 2024 profit plunges nearly 60 percent
March 17, 2025 at 05:02 PM UTC•By FilingReader AI
Sinopharm Group Co. Ltd. (HKEX: 1099) announced preliminary financial data for its subsidiary, Sinopharm Accord, revealing a substantial decrease in profitability for the year 2024. Net profit attributable to shareholders of the listed company fell by 59.83% to RMB642 million. Basic earnings per share also decreased by 59.93%.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:1099•Hong Kong Exchange
News Alerts
Get instant email alerts when Sinopharm publishes news
Free account required • Unsubscribe anytime